Individual Study / UKLWC

UK Collaborative Trial of Ovarian Cancer Screening - Longitudinal Women’s Cohort

UK Collaborative Trial of Ovarian Cancer Screening - Longitudinal Women’s Cohort

Initiatives -
Create an ‘open research’ platform for the study of common disease and delivery of precision medicine, specifically: (i) Identification of new drug targets for common conditions to enable drug development, repositioning and indication expansion. (ii) Discovery of novel risk prediction, screening, diagnostic and prognostic disease markers. *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
Start Year
End Year


Investigators Contacts
  • Prof. Usha Menon
    University College London


Study design
Population cohort
Supplementary Information

Marker Paper

Menon U, Gentry-Maharaj A, Ryan A, Sharma A, Burnell M, Hallett R, Lewis S, Lopez A, Godfrey K, Oram D, Herod J, Williamson K, Seif M, Scott I, Mould T, Woolas R, Murdoch J, Dobbs S, Amso N, Leeson S, Cruickshank D, McGuire A, Campbell S, Fallowfield L, Skates S, Parmar M, Jacobs I. Recruitment to multicentre trials--lessons from UKCTOCS: descriptive study. BMJ. 2008 Nov 13;337:a2079. doi: 10.1136/bmj.a2079. Erratum in: BMJ. 2008;337:a2976.

PUBMED 25964255


Sources of Recruitment
  • Individuals

Number of participants

Number of participants
Number of participants with biosamples
Supplementary Information
Postmenopausal women, aged 50-74 years were recruited through 13 trial centres in England, Wales and Northern Ireland.


Availability of data and biosamples